LayerBio, Inc. Announces Launch; Signs Option for Technology from MIT

November 20, 2013

New drug delivery company to focus on ophthalmology and wound care

CAMBRIDGE- President and CEO, Dr. Kenneth Mandell, announces the formation of LayerBio, Inc. and inks an exclusive option for a unique technology from Massachusetts Institute of Technology (MIT). Under this agreement, LayerBio will commercialize a drug delivery platform developed in the laboratory of Co-Founder Dr. Paula Hammond, David H. Koch Professor in Engineering and leading expert in biomaterials and drug delivery. Dr. Hammond maintains her faculty position at MIT and joins LayerBio as Chair of the Scientific Advisory Board.

“Securing an option agreement with MIT marks a significant event in the formation of LayerBio. Dr. Hammond represents the highest caliber of scientific expertise and the technology offers multiple opportunities for improved drug delivery in the fields of ophthalmology, wound care and other therapeutic areas,” commented Dr. Mandell.

LayerBio’s platform, LayerForm™, is a conformal, tunable and bioerodible polymer technology that enables coating and release of drugs from various medical devices. It is compatible with small molecules, nucleic acids and biologic drugs and has been tested on a variety of substrates, including bandages, sutures, ophthalmic lenses and other topical and implantable devices. There are numerous potential applications for LayerBio’s distinctive technology.

LayerBio will initially focus on applications in ophthalmology and wound care. These markets are rapidly-growing with significant unmet needs for effective drug delivery. “By targeting therapies in controlled fashion to the site of action, including drugs that are typically more challenging to deliver such as siRNA and biologics, our technology can improve safety, efficacy and convenience for patients,” said Dr. Hammond.

BioFlash

Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.